INDIA MARKET LENS
◆ Mixed

Oracle Life Sciences Partners With Wipro For Cloud-Based Drug Safety Operations

Wipro is in focus.

22 Sept 2026 · NDTV Profit

Oracle Life Sciences and Wipro will offer cloud-based pharmacovigilance services to help drugmakers streamline safety and compliance.

Against that, the stock is -1.4% on the day at ₹159.62, and has returned -8.0% over three months. It sits 42% below its 52-week high, which means a good deal of bad news was already in the price. The it sector has moved -3.2% over the same period, so Wipro is running 4.8 points behind its peers.

For Wipro, the question is how much of this is already reflected in the price and how much re-rates the it peer set alongside it.

  • The company directly in focus is WIPRO.
  • Sector exposure: IT.